Trial · NCT02597127
Adverse events904
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 904
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Angina pectoris | Cardiac disorders | Placebo (Single Dose) | 1 | 65 | |
| other | Angina pectoris | Cardiac disorders | Inclisiran 200 mg (Single Dose) | 2 | 60 | |
| other | Angina pectoris | Cardiac disorders | Inclisiran 300 mg (Single Dose) | 4 | 61 | |
| other | Angina pectoris | Cardiac disorders | Inclisiran 500 mg (Single Dose) | 1 | 65 | |
| other | Angina pectoris | Cardiac disorders | Placebo (Double Dose) | 2 | 62 | |
| other | Angina pectoris | Cardiac disorders | Inclisiran 100 mg (Double Dose) | 0 | 61 | |
| other | Angina pectoris | Cardiac disorders | Inclisiran 200 mg (Double Dose) | 2 | 62 | |
| other | Angina pectoris | Cardiac disorders | Inclisiran 300 mg (Double Dose) | 0 | 61 | |
| other | Abdominal pain | Gastrointestinal disorders | Placebo (Single Dose) | 2 | 65 | |
| other | Abdominal pain | Gastrointestinal disorders | Inclisiran 200 mg (Single Dose) | 3 | 60 | |
| other | Abdominal pain | Gastrointestinal disorders | Inclisiran 300 mg (Single Dose) | 2 | 61 | |
| other | Abdominal pain | Gastrointestinal disorders | Inclisiran 500 mg (Single Dose) | 0 | 65 | |
| other | Abdominal pain | Gastrointestinal disorders | Placebo (Double Dose) | 3 | 62 | |
| other | Abdominal pain | Gastrointestinal disorders | Inclisiran 100 mg (Double Dose) | 2 | 61 | |
| other | Abdominal pain | Gastrointestinal disorders | Inclisiran 200 mg (Double Dose) | 1 | 62 | |
| other | Abdominal pain | Gastrointestinal disorders | Inclisiran 300 mg (Double Dose) | 4 | 61 | |
| other | Constipation | Gastrointestinal disorders | Placebo (Single Dose) | 1 | 65 | |
| other | Constipation | Gastrointestinal disorders | Inclisiran 200 mg (Single Dose) | 4 | 60 | |
| other | Constipation | Gastrointestinal disorders | Inclisiran 300 mg (Single Dose) | 2 | 61 | |
| other | Constipation | Gastrointestinal disorders | Inclisiran 500 mg (Single Dose) | 1 | 65 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02597127/events